These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20600722)

  • 1. Isoxyl particles for pulmonary delivery: In vitro cytotoxicity and potency.
    Wang C; Hickey AJ
    Int J Pharm; 2010 Aug; 396(1-2):99-104. PubMed ID: 20600722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
    Sayes CM; Reed KL; Warheit DB
    Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Method of in vitro study of the sensitivity of mycobacteria to 4,4'-diisoamyloxythiocarbanilide (Isoxyl)].
    Tacquet A; Roos P; Devulder B; Martin G
    Ann Inst Pasteur Lille; 1965; 16():31-6. PubMed ID: 5895723
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoxyl aerosols for tuberculosis treatment: preparation and characterization of particles.
    Wang C; Hickey AJ
    AAPS PharmSciTech; 2010 Jun; 11(2):538-49. PubMed ID: 20339959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalable microparticles containing large payload of anti-tuberculosis drugs.
    Muttil P; Kaur J; Kumar K; Yadav AB; Sharma R; Misra A
    Eur J Pharm Sci; 2007 Oct; 32(2):140-50. PubMed ID: 17681458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages.
    Eidi H; Joubert O; Attik G; Duval RE; Bottin MC; Hamouia A; Maincent P; Rihn BH
    Int J Pharm; 2010 Aug; 396(1-2):156-65. PubMed ID: 20542101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring safety of liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophages.
    Changsan N; Nilkaeo A; Pungrassami P; Srichana T
    J Drug Target; 2009 Dec; 17(10):751-62. PubMed ID: 19863196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effervescent dry powder for respiratory drug delivery.
    Ely L; Roa W; Finlay WH; Löbenberg R
    Eur J Pharm Biopharm; 2007 Mar; 65(3):346-53. PubMed ID: 17156987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoxyl assays in plasma.
    Wang C; Garcia-Contreras L; Muttil P; Hickey AJ
    J Pharm Biomed Anal; 2012 Feb; 60():1-6. PubMed ID: 22119164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles with silicon micron-sized particles in RAW 264.7 macrophages.
    Choi J; Zhang Q; Reipa V; Wang NS; Stratmeyer ME; Hitchins VM; Goering PL
    J Appl Toxicol; 2009 Jan; 29(1):52-60. PubMed ID: 18785685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis.
    Phetsuksiri B; Jackson M; Scherman H; McNeil M; Besra GS; Baulard AR; Slayden RA; DeBarber AE; Barry CE; Baird MS; Crick DC; Brennan PJ
    J Biol Chem; 2003 Dec; 278(52):53123-30. PubMed ID: 14559907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies.
    Rojanarat W; Changsan N; Tawithong E; Pinsuwan S; Chan HK; Srichana T
    Int J Mol Sci; 2011; 12(7):4414-34. PubMed ID: 21845086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
    Dong Y; Ng WK; Hu J; Shen S; Tan RB
    Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of pulmonary tuberculosis with Isoxyl (bacteriological considerations)].
    Taranger J
    Rev Tuberc Pneumol (Paris); 1967; 31(1):68-72. PubMed ID: 4962524
    [No Abstract]   [Full Text] [Related]  

  • 16. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
    Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of thiocarbonylides (isoxyl and ethoxide) under experimental and clinical conditions].
    Shmelev NA; Kozulitsyna TI; Utkin VV; Poleshchuk AK; Stepanian ES
    Probl Tuberk; 1966; 44(6):13-23. PubMed ID: 4968672
    [No Abstract]   [Full Text] [Related]  

  • 18. Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis.
    Hwang SM; Kim DD; Chung SJ; Shim CK
    J Control Release; 2008 Jul; 129(2):100-6. PubMed ID: 18538437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
    Azarmi S; Tao X; Chen H; Wang Z; Finlay WH; Löbenberg R; Roa WH
    Int J Pharm; 2006 Aug; 319(1-2):155-61. PubMed ID: 16713150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
    Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
    Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.